Related Experiment Video
Updated: Jun 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to
Jitka Malcikova1, Boris Tichy1, Jiri Damborsky2
1Center of Molecular Biology and Gene Therapy, Department of Internal Medicine - Hematooncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, CZ-625 00 Brno, Czech Republic.
Abstract:
Sequence-specific DNA binding is the key function through which tumor suppressor p53 exerts transactivation of the downstream target genes, often being impaired in cancer cells by mutations in the TP53 gene. Functional protein microarray technology enables a high-throughput parallel analysis of protein properties within one experiment under the same conditions. Using an array approach, we analyzed the DNA binding activity of wild type p53 protein and of 49 variants. Our results show significant differences in the binding properties between the p53 mutants. The C-terminal mutant R337C displayed the highest DNA binding activity on the array. However, the same mutant showed only a partial activation in the reporter gene assay and almost no activation of downstream target genes after transfection of expression vector into cells lacking endogenous p53. These observations demonstrate that DNA binding itself is not sufficient for activating the p53 target genes in at least some of the p53 mutants and, therefore, in vitro studies might not always reflect in vivo conditions.
Insights
Tumor suppressor p53
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Sequence-specific DNA binding is crucial for tumor suppressor p53 function.
- TP53 gene mutations impair p53 activity in cancer.
- Protein microarray technology allows high-throughput analysis of protein properties.
Purpose of the Study:
- To investigate the DNA binding activity of wild type p53 and 49 variants using a protein microarray approach.
- To compare in vitro DNA binding with in vivo transactivation activity of p53 mutants.
Main Methods:
- Utilized functional protein microarray technology for parallel analysis of p53 variants.
- Assessed DNA binding activity of wild type p53 and 49 mutants.
- Evaluated transactivation activity using reporter gene assays and gene expression analysis in p53-null cells.
Main Results:
- Significant differences in DNA binding properties were observed among p53 mutants.
- The C-terminal mutant R337C exhibited the highest DNA binding activity on the array.
- R337C showed only partial reporter gene activation and minimal downstream target gene activation in cells.
Conclusions:
- DNA binding alone is insufficient for p53 target gene activation in certain mutants.
- In vitro DNA binding studies may not always accurately predict in vivo functional outcomes.
- Understanding p53 mutant behavior is critical for cancer therapy development.
More Related Videos
06:38High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
Published on: February 7, 2019
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Abnormal Proliferation
DNA Microarrays
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...